Culture, psychosomatics and substance abuse: The example of body image drugs

Psychotherapy and Psychosomatics

Volumn 81, Issue 2, 2012, Pages 73-78

  Kanayama, Gen ^a,b   Hudson, James I ^a,b   Pope Jr , Harrison G ^a,b  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; ANDROGEN; CANNABIS; COCAINE; GROWTH HORMONE; METHAMPHETAMINE; OPIATE; TESTOSTERONE; THYROID HORMONE;

BODY FAT; BODY IMAGE; CHINA; CULTURAL ANTHROPOLOGY; DRUG ABUSE; EATING DISORDER; HUMAN; NEW ZEALAND; NORWAY; PRIORITY JOURNAL; PSYCHOSOMATICS; QUESTIONNAIRE; REVIEW; SUBSTANCE ABUSE;

ADULT; ANABOLIC AGENTS; ANDROGENS; BODY IMAGE; CULTURE; HUMANS; MALE; PSYCHOSOMATIC MEDICINE; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84855867299     PISSN: 00333190     EISSN: 14230348     Source Type: Journal    
DOI: 10.1159/000330415     Document Type: Review

References (76)

1. Degenhardt L, Chiu WT, Sampson N, Kessler RC, Anthony JC, Angermeyer M, Bruffaerts R, de Girolamo G, Gureje O, Huang Y, Karam A, Kostyuchenko S, Lepine JP, Mora ME, Neumark Y, Ormel JH, Pinto-Meza A, Posada-Villa J, Stein DJ, Takeshima T, Wells JE: Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys. PLoS Med 2008; 5:e141.
2. Grelotti DJ, Kanayama G, Pope HG Jr: Remission of persistent methamphetamineinduced psychosis after electroconvulsive therapy: presentation of a case and review of the literature. Am J Psychiatry 2010; 167: 17-23.
3. Wada K, Ozaki S, Kondo A: Current situation of and the political measures for drug abuse/dependence (in Japanese). Nihon Arukoru Yakubutsu Igakkai Zasshi 2008; 43: 120-131.
4. Tominaga M, Kawakami N, Ono Y, Nakane Y, Nakamura Y, Tachimori H, Iwata N, Uda H, Nakane H, Watanabe M, Naganuma Y, Furukawa TA, Hata Y, Kobayashi M, Miyake Y, Takeshima T, Kikkawa T: Prevalence and correlates of illicit and non-medical use of psychotropic drugs in Japan: findings from the World Mental Health Japan Survey 2002-2004. Soc Psychiatry Psychiatr Epidemiol 2009; 44: 777-783.
5. Greberman SB, Wada K: Social and legal factors related to drug abuse in the United States and Japan. Public Health Rep 1994; 109: 731-737.
6. Kanayama G, Hudson JI, Pope HG Jr: Illicit anabolic-androgenic steroid use. Horm Behav 2010; 58: 111-121.
7. Kanayama G, Gruber AJ, Pope HG Jr, Borowiecki JJ, Hudson JI: Over-the-counter drug use in gymnasiums: an underrecognized substance abuse problem? Psychother Psychosom 2001; 70: 137-140. (Pubitemid 32429714)
8. Gruber AJ, Pope HG Jr: Psychiatric and medical effects of anabolic-androgenic steroid use in women. Psychother Psychosom 2000; 69: 19-26.
9. Kouri EM, Pope HG Jr, Katz DL, Oliva P: Fatfree mass index in users and nonusers of anabolic-androgenic steroids. Clin J Sport Med 1995; 5: 223-228.
10. Kanayama G, Hudson JI, Pope HG Jr: Longterm psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern? Drug Alcohol Depend 2008; 98: 1-12.
11. Parkinson AB, Evans NA: Anabolic androgenic steroids: a survey of 500 users. Med Sci Sports Exerc 2006; 38: 644-651.
12. Kanayama G, Pope HG Jr, Hudson JI: 'Body image' drugs: a growing psychosomatic problem. Psychother Psychosom 2001; 70: 61-65. (Pubitemid 32217875)
13. Brennan BP, Kanayama G, Hudson JI, Pope HG Jr: Illicit human growth hormone abuse in male weightlifters. Addict Behav 2011; 20: 9-13.
14. Hildebrandt T, Alfano L, Langenbucher JW: Body image disturbance in 1,000 male appearance-and performance-enhancing drug users. J Psychiatr Res 2010; 44: 841-846.
15. Baggish AL, Weiner RB, Kanayama G, Hudson JI, Picard MH, Hutter AM Jr, Pope HG Jr: Long-term anabolic-androgenic steroid use is associated with left ventricular dysfunction. Circ Heart Fail 2010; 3: 472-476.
16. Pope HG Jr, Katz DL: Psychiatric effects of exogenous anabolic-androgenic steroids; in Wolkowitz OM, Rothschild AJ (eds): Psychoneuroendocrinology. The Scientific Basis of Clinical Practice. Washington, American Psychiatric Press, 2003, pp 331-358.
17. Kanayama G, Brower KJ, Wood RI, Hudson JI, Pope HG Jr: Anabolic-androgenic steroid dependence: an emerging disorder. Addiction 2009; 104: 1966-1978.
18. Kanayama G, Brower KJ, Wood RI, Hudson JI, Pope HG Jr: Treatment of anabolic-androgenic steroid dependence: emerging evidence and its implications. Drug Alcohol Depend 2010; 109: 6-13.
19. Pope HG Jr, Kean J, Nash A, Kanayama G, Samuel DB, Bickel WK, Hudson JI: A diagnostic interview module for anabolic-androgenic steroid dependence: preliminary evidence of reliability and validity. Exp Clin Psychopharmacol 2010; 18: 203-213.
20. Nilsson S, Spak F, Marklund B, Baigi A, Allebeck P: Attitudes and behaviors with regards to androgenic anabolic steroids among male adolescents in a county of Sweden. Subst Use Misuse 2004; 39: 1183-1197. (Pubitemid 39166944)
21. Pallesen S, Josendal O, Johnsen BH, Larsen S, Molde H: Anabolic steroid use in high school students. Subst Use Misuse 2006; 41: 1705-1717. (Pubitemid 44844159)
22. Skarberg K, Nyberg F, Engström I: Multisubstance use as a feature of addiction to anabolic-androgenic steroids. Eur Addict Res 2009; 15: 99-106.
23. Thiblin I, Petersson A: Pharmacoepidemiology of anabolic androgenic steroids: a review. Fundam Clin Pharmacol 2005; 19: 27-44. (Pubitemid 40204345)
24. Johnston LD, O'Malley PM, Bachman JG, Schulenberg JE: Monitoring the future national survey results on drug use, 1975-2009. Vol II. College students and adults ages 19-50. NIH Publ No. 10-7585. Bethesda, National Institute on Drug Abuse, 2010. http://monitoringthefuture.org/new.html (accessed June 12, 2011).
25. McCabe SE, Brower KJ, West BT, Nelson TF, Wechsler H: Trends in non-medical use of anabolic steroids by US college students: results from four national surveys. Drug Alcohol Depend 2007; 90: 243-251. (Pubitemid 47287715)
26. Baker JS, Graham MR, Davies B: Steroid and prescription medicine abuse in the health and fitness community: a regional study. Eur J Intern Med 2006; 17: 479-484. (Pubitemid 44708733)
27. Copeland J, Peters R, Dillon P: A study of 100 anabolic-androgenic steroid users. Med J Aust 1998; 168: 311-312. (Pubitemid 28132584)
28. Handelsman DJ, Gupta L: Prevalence and risk factors for anabolic-androgenic steroid abuse in Australian high school students. Int J Androl 1997; 20: 159-164. (Pubitemid 27470087)
29. Goldfield GS, Woodside DB: Body image, disordered eating, and anabolic steroids in male bodybuilders: current versus former users. Phys Sportsmed 2009; 37: 111-114.
30. Melia P, Pipe A, Greenberg L: The use of anabolic-androgenic steroids by Canadian students. Clin J Sport Med 1996; 6: 9-14. (Pubitemid 26104556)
31. Galduróz JC, Noto AR, Nappo SA, Carlini EA: Household survey on drug abuse in Brazil: study involving the 107 major cities of the country-2001. Addict Behav 2005; 30: 545-556. (Pubitemid 40249407)
32. Kokkevi A, Fotiou A, Chileva A, Nociar A, Miller P: Daily exercise and anabolic steroids use in adolescents: a cross-national European study. Subst Use Misuse 2008; 43: 2053-2065.
33. Racho D, Pokrywka L, Suchecka-Racho K: Prevalence and risk factors of anabolic-androgenic steroids (AAS) abuse among adolescents and young adults in Poland. Soz Praventivmed 2006; 51: 392-398. (Pubitemid 44873623)
34. Wanjek B, Rosendahl J, Strauss B, Gabriel HH: Doping, drugs and drug abuse among adolescents in the State of Thuringia (Germany): prevalence, knowledge and attitudes. Int J Sports Med 2007; 28: 346-353. (Pubitemid 46640303)
35. Takahashi M, Tatsugi T, Kohno Y: Telephone counseling of athletes abusing anabolic-androgenic steroids. J Sports Med Phys Fitness 2007; 47: 356-360.
36. Takayanagi A, Kobayashi K, Hashimoto K, Kato R, Masumori N, Itoh N, Tsukamoto T: Case of androgenic-anabolic steroid abuse caused hypogonadotropic hypogonadism (in Japanese). Nippon Hinyokika Gakkai Zasshi 2008; 99: 729-732.
37. Takahashi M: A case of nail destruction as a possible side effect of anabolic-androgenic steroid doping (in Japanese). Nihon Tairyoku Igakkai 1994; 43: 66-74.
38. Takahashi M: Gynecomastia as a side effect of anabolic-androgenic steroid doping in a Japanese amateur bodybuilder (in Japanese). Nihon Tairyoku Igakkai 1996; 45: 237-244. (Pubitemid 126502304)
39. Yang CF, Gray PB, Zhang J, Pope HG Jr: Second to fourth digit ratios, sex differences, and behavior in Chinese men and women. Soc Neurosci 2009; 4: 49-59.
40. Lu L, Wang X: Drug addiction in China. Ann NY Acad Sci 2008; 1141: 304-317.
41. Chung H, Park M, Hahn E, Choi H, Choi H, Lim M: Recent trends of drug abuse and drug-associated deaths in Korea. Ann N Y Acad Sci 2004; 1025: 458-464. (Pubitemid 39643894)
42. Sturluson S: The Younger Edda, also called Snorre's Edda or the Prose Edda, transl by Anderson, RB. Chicago, Scott, Foresman, 1901. http://www.gutenberg.org/etext/18947 (accessed June 12, 2011).
43. Pope HG Jr, Olivardia R, Gruber A, Borowiecki J: Evolving ideals of male body image as seen through action toys. Int J Eat Disord 1999; 26: 65-72. (Pubitemid 29227829)
44. Pope HG Jr, Olivardia R, Borowiecki JJ, Cohane GH: The growing commercial value of the male body: a longitudinal survey of advertising in women's magazines. Psychother Psychosom 2001; 70: 189-192. (Pubitemid 32620185)
45. Pope HG Jr, Phillips K, Olivardia R: The Adonis Complex. The Secret Crisis of Male Body Obsession. New York, Simon and Schuster, 2000.
46. Anonymous: Kojiki. Record of Ancient Matters, transl by Chamberlain, BH. Rutland, Charles E Tuttle, 1981.
47. Yang CF, Gray P, Pope HG Jr: Male body image in Taiwan versus the West: Yanggang Zhiqi meets the Adonis complex. Am J Psychiatry 2005; 162: 263-269. (Pubitemid 40216205)
48. Confucius: The Analects, transl by Lau, DC. New York, Penguin, 1979.
49. Pope HG Jr, Gruber AJ, Mangweth B, Bureau B, de Col C, Jouvent R, Hudson JI: Body image perception among men in three countries. Am J Psychiatry 2000; 157: 1297-1301. (Pubitemid 30659814)
50. Kanayama G, Pope HG Jr: Gods, men, and muscle dysmorphia. Harv Rev Psychiatry 2011; 19: 95-98.
51. Fava GA: Morselli's legacy: dysmorphophobia. Psychother Psychosom 1992; 58: 117-118. (Pubitemid 23031029)
52. Snaith P: Body image disorders. Psychother Psychosom 1992; 58: 119-124. (Pubitemid 23031030)
53. Kowner R: When ideals are too 'far off': physical self-ideal discrepancy and body dissatisfaction in Japan. Genet Soc Gen Psychol Monogr 2004; 130: 333-361. (Pubitemid 41662121)
54. Lerner RM, Iwawaki S, Chihara T, Sorell GT: Self-concept, self-esteem, and body attitudes among Japanese male and female adolescents. Child Dev 1980; 51: 847-855.
55. Sano A, Le DS, Tran MH, Pham HT, Kaneda M, Murai E, Kamiyama H, Oota Y, Yamamoto S: Study on factors of body image in Japanese and Vietnamese adolescents. J Nutr Sci Vitaminol (Tokyo) 2008; 54: 169-175. (Pubitemid 351754006)
56. Yuasa Y: The Body, Self-Cultivation, and Ki-Energy, transl by Nagamoto S, Hull M. Albany, State University of New York Press, 1993.
57. Minamoto R: A study of practical learning in the beginning of the modern period (in Japanese). Tokyo, Sbunsha, 1980.
58. Mangweth B, Pope HG Jr, Kemmler G, Ebenbichler C, Hausmann A, de Col C, Kreutner B, Kinzl J, Biebl W: Body image and psychopathology in male bodybuilders. Psychother Psychosom 2001; 70: 38-43. (Pubitemid 32041461)
59. Chisuwa N, O'Dea JA: Body image and eating disorders amongst Japanese adolescents: a review of the literature. Appetite 2010; 54: 5-15.
60. Kayano M, Yoshiuchi K, Al-Adawi S, Viernes N, Dorvlo AS, Kumano H, Kuboki T, Akabayashi A: Eating attitudes and body dissatisfaction in adolescents: cross-cultural study. Psychiatry Clin Neurosci 2008; 62: 17-25. (Pubitemid 351257708)
61. Chen H, Jackson T: Prevalence and sociodemographic correlates of eating disorder endorsements among adolescents and young adults from China. Eur Eat Disord Rev 2008; 16: 375-385.
62. Tong J, Miao SJ, Wang J, Zhang JJ, Wu HM, Li T, Hsu LK: Five cases of male eating disorders in Central China. Int J Eat Disord 2005; 37: 72-75. (Pubitemid 40262179)
63. Mangweth B, Pope HG Jr, Hudson JI, Olivardia R, Kinzl J, Biebl W: Eating disorders in Austrian men: an intracultural and crosscultural comparison study. Psychother Psychosom 1997; 66: 214-221. (Pubitemid 27331602)
64. Herodotus: Readings in Ancient History, vol I, transl by Rawlinson G. Boston, Allyn and Bacon, 1912.
65. Halpern JH: Hallucinogens: an update. Curr Psychiatry Rep 2003; 5: 347-354. (Pubitemid 38899228)
66. Halpern JH, Sherwood AR, Hudson JI, Yurgelun-Todd D, Pope HG Jr: Psychological and cognitive effects of long-term peyote use among Native Americans. Biol Psychiatry 2005; 58: 624-631. (Pubitemid 41565577)
67. Pope HG Jr: Tabernanthe iboga: an African narcotic plant of social importance. Econ Bot 1969; 23: 174-184.
68. Suwaki H: Substance-abuse trends in Japan. Public Health Rev 1983; 11: 199-222.
69. Fendrich M, Johnson TP: Race/ethnicity differences in the validity of self-reported drug use: results from a household survey. J Urban Health 2005; 82(suppl 3):iii67-iii81. (Pubitemid 41442970)
70. Greely H, Sahakian B, Harris J, Kessler RC, Gazzaniga M, Campbell P, Farah MJ: Towards responsible use of cognitive-enhancing drugs by the healthy. Nature 2008; 456: 702-705.
71. Kennett GA, Clifton PG: New approaches to the pharmacological treatment of obesity: can they break through the efficacy barrier? Pharmacol Biochem Behav 2010; 97: 63-83.
72. Cyranoski D: Malaysian researchers bet big on home-grown Viagra. Nat Med 2005; 11: 912. (Pubitemid 41294428)
73. Deluca P, Schifano F: Searching the Internet for drug-related web sites: analysis of online available information on ecstasy (MDMA). Am J Addict 2007; 16: 479-483. (Pubitemid 350223237)
74. Fox N, Ward K, O'Rourke A: Pro-anorexia, weight-loss drugs and the internet: an 'antirecovery' explanatory model of anorexia. Sociol Health Illn 2005; 27: 944-971. (Pubitemid 41796891)
75. Halpern JH, Pope HG Jr: Hallucinogens on the Internet: a vast new source of underground drug information. Am J Psychiatry 2001; 158: 481-483. (Pubitemid 32205209)
76. Hesse M: Enhancement drugs: are there limits to what we should enhance and why? BMC Med 2010; 8: 50.